Losartan linked to risk of hypotension and AKI among COVID-19 patients hospitalized for pneumonia: Study Jacinthlyn Sylvia23 July 2024 7:15 AM ISTA recent research by Karen Tran and colleagues suggested that angiotensin receptor blockers (ARBs) should not be added to the treatment of patients...
ARBs and ACE Inhibitors may prevent kidney failure in CKD patients on dialysis, States study Jacinthlyn Sylvia16 July 2024 7:45 AM ISTA new study published in Annals of Internal Medicine found that in patients with advanced chronic kidney disease (CKD), starting...
Angiotensin Receptor Blockers Linked to Reduced Risk of New-Onset Epilepsy in Hypertensive Patients: Study Medha Baranwal26 Jun 2024 10:00 AM ISTUSA: Recent medical research has sparked interest in the potential link between angiotensin receptor blockers (ARBs), commonly prescribed for...
Hypertension Management in Pre- and Post- Percutaneous Coronary Intervention - An Expert Opinion MD Brand Connect10 Jun 2024 11:00 AM ISTAngiotensin receptor blockers (ARBs) are the most preferred antihypertensive agents among Indian cardiologists for managing hypertension in...
Combination therapy with ARBs and Beta-blockers for post-PCI patients with hypertension-Expert Opinion of Indian Cardiologists Dr Jeegar Dattani4 Jun 2024 11:00 AM ISTThe expert opinion is the first of its kind, guiding Indian Cardiologists in managing hypertension in post-PCI patients with comorbidities. A total of...
Combination of ARBs and beta blockers may delay need for surgery in patients with Marfan syndrome Dr. Kamal Kant Kohli6 Sept 2022 9:00 AM ISTAccording to new patient-level meta-analysis both angiotensin receptor blockers (ARBs) as well as beta-blockers reduce the rate of aortic enlargement...
Hypertension among COVID-19 patients associated with poor prognosis, finds study Dr.Niharika Harsha B21 Aug 2022 8:00 PM ISTA new investigation revealed that in-hospital mortality and adverse outcomes in COVID-19 are due to hypertension, but angiotensin-converting enzyme...
ACEIs or ARBs may lower risk of mortality in oesophagal and gastric cancer patients Dr. Shravani Dali3 May 2022 9:00 PM ISTPostdiagnosis use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) is associated with a lower risk for...
Mineralocorticoid Receptor Antagonists offer great economic value in HF patients: AHA/ACC/HFSA 2022. Dr. Prem Aggarwal28 April 2022 12:45 PM ISTMineralocorticoid Receptor Antagonists (MRA) have a great potential economic value to offer in patients with Heart Failure with mild ejection fraction...
Prolonged Exposure to ARB Linked with Cancer Risk MD Bureau7 March 2022 9:15 AM ISTAngiotensin-receptor blockers (ARBs) are a class of drugs approved for the treatment of several common conditions, such as hypertension and heart...
Telmisartan use reduces risk of dementia in hypertensive patients with Type 2- DM: Study Dr. Shravani Dali28 July 2021 11:45 AM ISTAdministering Telmisartan in type-2 diabetes patients with hypertension is linked with reduced risk of dementia and ischemic stroke, suggests a...
ARBs vs ACE Inhibitors as First-Line Treatment of hypertension: Study Hina Zahid27 July 2021 10:00 AM ISTYORK, NY - Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors are first line drugs for controlling high blood pressure.People...
